|
KMID : 1030220220230010007
|
|
Journal of Korean Diabetes
2022 Volume.23 No. 1 p.7 ~ p.11
|
|
|
Microbiome and Diabetes
|
|
Kim Jin-Hwa
|
|
|
Abstract
|
|
|
|
The prevalence of metabolic diseases such as obesity, type 2 diabetes, and insulin resistance continues to rise. These conditions are associated with multiple social, genetic, and environmental risk factors, including the human gut microbiota, which has emerged as a critical mediator linked to metabolic disease. Recent evidence suggests that the gut microbiota has personalized effects on the gut-brain axis, which controls metabolic function. Gut microbiota can be a great source of prognostic biomarkers and therapies for metabolic diseases. The microbiome also influences immune system development and homeostasis. In this review, I summarize recent findings regarding the association between the gut microbiome and type 2 diabetes. These findings will inform future diabetes mellitus prevention, diagnosis, and treatment strategies.
|
|
|
KEYWORD
|
|
|
Diabetes mellitus, type 2, Microbiome, Microbiota
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|